Reishi Mushroom 4:1 Extract Powder by TerraVita Premium Collection — Ingredients, Evidence & Safety

Product Label

Label for Reishi Mushroom 4:1 Extract Powder

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.25 Teaspoon(s) Serving Size

28 Servings

Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Reishi Mushroom Extract, Powder

1000 mg

📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews

This product: 1000mg

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (86% of products) Nutrient (9% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions

Additional Information

TerraVita is an exclusive line of premium natural products that use the finest, purest and most potent ingredients in the world. TerraVita's hallmarks are the highest possible standards of purity, potency, stability and freshness. All products are prepared with the greatest quality control, from raw materials through the entire manufacturing process, right up to the moment your product is sealed for freshness and shipped to you.

Please recycle!

Product Details

UPC / SKU 0 64435 20595 9

DSLD Entry Date 2023-06-22

Product Type Botanical

Form Powder

Brand TerraVita Premium Collection

DSLD ID 290762

Data Updated 2026-04-11

Research Evidence

6 Research Sources

60 Avg Quality Score

3 Meta Analysis

3 Rct

B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

B Ganoderma lucidum (Reishi mushroom) for cancer treatment

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients

Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021

PubMed DOI

C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India

Rct International journal of medicinal mushrooms 2024

PubMed DOI

C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial

Rct Integrative cancer therapies 2020

PubMed DOI

View all evidence for Reishi →